Sign in
Stories
Walgreens Boots Alliance Sells Cencora Shares
Share
Boots to Close 100 UK Stores
CVS Health's Q4 Medical Costs
CVS Health's Q4 Medical Costs Rise
Overview
API
Walgreens Boots Alliance sells shares of Cencora for $992 million, with Cencora planning to repurchase about $50 million of its shares. The proceeds will be used for debt paydown and general corporate purposes. The strategic partnership between the two companies remains unaffected.
Ask a question
How does this transaction reflect broader trends in the pharmaceutical industry and corporate partnerships?
How might the sale of Cencora shares impact Walgreens Boots Alliance's financial position and strategic objectives?
What are the potential implications of Cencora's plan to repurchase its shares on the company's growth and market position?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage